Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells-Reference-Cited by-同舟云学术

Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells

Published:2023-09 Issue: Volume:139 Page:91-105
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Gonzàlez-Farré Mònica^ORCID,Gibert Joan,Santiago-Díaz Pablo,Menéndez Silvia,Monzonis Xavier,Olivares Francesc,Riera Xènia,López David,Torner Ariadna,Casado Beatriz,Bellosillo Beatriz,Lloveras Belén,Casadevall David,Rovira Ana,Servitja Sònia,Albanell Joan,Vázquez Ivonne,Comerma Laura

Funder

Sociedad Española de Oncología Médica

Federación Española de Enfermedades Raras

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. Triple-negative breast cancer: epidemiological considerations and recommendations;Boyle;Ann Oncol,2012

2. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014;Salgado;Ann Oncol,2015

3. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy;Denkert;Lancet Oncol,2018

4. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients;Ali;Ann Oncol,2014

5. Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer;Wouters;Clin Cancer Res,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software;Journal of Visualized Experiments;2024-04-12

2. Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications;MedComm;2024-03